
    
      All patients will receive the same dose of the study treatment over 6 months. For each
      participant the study will last approximately one year with follow up visits after the
      treatment period of 6 months is completed. The visits will include blood draws,
      electromyography (EMG), vital sign checks, neurological and physical exams, pulmonary testing
      with forced vital capacity (FVC), and questionnaires.
    
  